Certara, Inc.

Certara accelerates medicines using proprietary biosimulation software, technology and services that transform traditional drug discovery and development. Our clients include more than 2,000 biopharmaceutical companies, academic institutions and regulatory agencies across 62 countries. Our integrated approach combined with our 1,100+ strong team of world-class scientists and experts enable informed decision-making, higher R&D productivity, and improved patient outcomes. With our quantitative approach, we anticipate and address critical drug discovery and development decisions. Certara works across all therapeutic areas and innovative therapies, including immuno-oncology, rare disease, CNS, respiratory disease, gene therapy, and global health, providing translational solutions from discovery to patient access.